ATLAS Market profile
Menu
Atlas · Symbols · ETFs · ARKI

Atlas market file · Etf · United States

ARK DIET Q2 Buffer ETFARKI

Last close
21.51
Change
+2.87%
86-bar range
19.89 – 22.71
As of
4 Aug 2026

ARK DIET Q2 Buffer ETF is an exchange-traded fund listed as ARKI on BATS. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot BATS:ARKI

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

22.794622.047321.320.552719.805401 Apr02 Jun04 Aug

up candle   down candle

Latest close21.51
Day change+2.87%
Window high22.71
Window low19.89
86-bar change+6.33%
SnapshotDaily · 86 bars
As of2026-08-04 13:30 UTC

Weekly outlook: the last 20 weekly closes (+5.85% over the window).

22.558820.161230 Mar04 Aug

Source rail: Yahoo Finance chart API (ARKI). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for ARKI. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

ARKI public profile

Company

Exchange-traded fund. ARK DIET Q2 Buffer ETF is connected to current market context, cited company sources and its retained research file.

Market

ARK DIET Q2 Buffer ETF trades as ARKI on BATS. ARK DIET Q2 Buffer ETF (ARKI) has a latest verified close of 21.51, up 2.87%, dated 4 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. ARKI stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

Institutional Market Wit ● Sourced Research File

The ARKI DIET Q2 Buffer ETF wants you to believe it has solved the problem of eating your greens and still enjoying dessert. The pitch is a diet theme wrapped in a buffer strategy, which in plain English means the fund promises to absorb some market losses up to a cap, like a crash helmet for your portfolio. But the glossy marketing material on Nasdaq tells you very little about what is actually inside the basket. The SEC EDGAR search confirms the fund exists and is registered, but the holdings list remains a mystery unless you dig into the full prospectus. So the real diet here might be on transparency. (source: SEC EDGAR, https://www.sec.gov/edgar/search/#/q=ARKI)

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for ARK DIET Q2 Buffer ETF today

Open full report
ARKI daily contextvalidated public digest3 source rail2026-08-07 02:40 UTC

ARKI, the ARK DIET Q2 Buffer ETF, is listed on Nasdaq and trades under that ticker. The fund markets itself as a diet-themed buffer strategy, promising to limit downside losses through an options-based approach. The name alone suggests a blend of discipline and indulgence, but the supplied evidence does not include the specific holdings, expense ratio, or AUM that would let a reader judge whether the wrapper delivers on its pitch.

The fund is an exchange-traded product that uses a buffer mechanism, typically a defined outcome strategy that absorbs a set percentage of losses in exchange for a cap on gains. This is not a company story; it is a wrapper story. The issuer sells a theme, and the real work is done by the basket of securities and the derivatives overlay. The evidence from SEC EDGAR confirms the fund is registered, but the filings are not parsed in this run, so the exact rules of the buffer and the cap remain unproven.

The FINRA Fund Analyzer is a source that would normally provide the expense ratio and fee data, but no parsed figures were supplied. The Nasdaq market activity page shows the fund trades, but volume and bid-ask spread are not included in the evidence. This means the reader cannot assess liquidity or cost of trading. The tension here is between the glossy marketing and the opaque reality of the basket.

What changed on this file is that the fund exists and is trading. What remains unproven is the financial detail that would allow a proper analysis: the expense ratio, the buffer percentage, the cap, the top holdings, and the AUM. The evidence is thin, but it identifies the correct sources for deeper investigation. The SEC EDGAR link leads to the fund's registration documents, the FINRA link leads to fee data, and the Nasdaq link leads to live trading data.

Until those sources are parsed, the file can only establish that ARKI is a thematic buffer ETF with a diet branding. The next step would be to pull the prospectus from EDGAR to confirm the buffer terms, and to run the FINRA analyzer for the expense ratio. The market activity on Nasdaq would then need volume and spread data to assess whether the fund has enough liquidity for a typical investor.

Sources & evidence · 3 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
ARKI
Exchange
BATS
Sector
Us Public Etf Directory
Region
United States
Asset class
Etf
Directory source
Nasdaq Trader
TradingView
Source authority

ARKI evidence rails

Atlas uses the specific public rails available for ARKI: Nasdaq Trader, TradingView, FRED, Atlas methodology. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 4 rails

Open an Atlas research path on ARKI

FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for ARKI Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep ARKI research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

ARKI FAQ

What is ARK DIET Q2 Buffer ETF (ARKI)?ARK DIET Q2 Buffer ETF (ARKI) has a latest verified close of 21.51, up 2.87%, dated 4 Aug 2026. Use this page to check the price chart, company context, source-backed...

ARK DIET Q2 Buffer ETF (ARKI) has a latest verified close of 21.51, up 2.87%, dated 4 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for ARKI?ARK DIET Q2 Buffer ETF (ARKI) has a latest verified close of 21.51, up 2.87%, dated 4 Aug 2026. It brings the latest available chart, company context, cited sources,...

ARK DIET Q2 Buffer ETF (ARKI) has a latest verified close of 21.51, up 2.87%, dated 4 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. ARKI stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

How often is the ARKI page updated?The ARKI public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The ARKI public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for ARKI?The ARKI file starts with Nasdaq Trader and TradingView BATS:ARKI. The page separates verified market context from company evidence and shows open evidence gaps instead...

The ARKI file starts with Nasdaq Trader and TradingView BATS:ARKI. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on ARKI?Yes. The workstation can open ARKI, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open ARKI, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this ARKI page investment advice?No. The ARKI page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The ARKI page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →